SOURCE: Syneron Medical Ltd.

Syneron Medical Ltd.

January 28, 2011 09:00 ET

Syneron Medical to Report Fourth Quarter and Full Year 2010 Financial Results on February 16, 2011

YOKNEAM, ISRAEL--(Marketwire - January 28, 2011) - Syneron Medical Ltd. (NASDAQ: ELOS), the leading global aesthetic device company, today announced that it will release fourth quarter and full year 2010 financial results before the market opens on Wednesday, February 16, 2011. The earnings release will be available on Syneron's Web site at www.syneron.com.

Syneron management will host a conference call and a live Web cast at 8:30 a.m. (ET) on the same day. A question & answer session will follow management's discussion of events in the fourth quarter and full year 2010.

Investors and analysts may participate in the conference call using the following dial-in numbers:

US (toll free): 877-844-6886
International: 970-315-0315

The conference passcode for both is 31269957.

Investors and other interested parties can also access a live Web cast of the conference call through the Investor Overview page on Syneron's Web site at www.syneron.com. Please log-in at least 10 minutes prior to the conference call in order to download the applicable audio software. Following the conclusion of the call, a replay of the Web cast will be available within 24 hours on the Company's Web site.

About Syneron Medical Ltd.

Syneron Medical Ltd. (NASDAQ: ELOS) is the leading global aesthetic device company with a comprehensive product portfolio and a global distribution footprint. The Company's technology enable physicians to provide advanced solutions for a broad range of medical-aesthetic applications including body contouring, hair removal, wrinkle reduction, rejuvenation of the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite. The Company sells its products under two distinct brands, Syneron and Candela. Founded in 2000, the corporate, R&D, and manufacturing headquarters for Syneron Medical Ltd. are located in Israel. Syneron also has R&D and manufacturing operations in the US. The company markets and services and supports its products in 86 countries. It has offices in North America, France, Germany, Italy, Portugal, Spain, UK, Australia, China, Japan, and Hong Kong and distributors worldwide. Additional information can be found at www.syneron.com

Contact Information